KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Exact Sciences (EXAS) Leases (2016 - 2025)

Exact Sciences has reported Leases over the past 16 years, most recently at $122.3 million for Q4 2025.

  • Quarterly Leases rose 4.6% to $122.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122.3 million through Dec 2025, up 4.6% year-over-year, with the annual reading at $122.3 million for FY2025, 4.6% up from the prior year.
  • Leases was $122.3 million for Q4 2025 at Exact Sciences, up from $121.1 million in the prior quarter.
  • Over five years, Leases peaked at $175.9 million in Q3 2022 and troughed at $9.5 million in Q2 2022.
  • The 5-year median for Leases is $142.9 million (2023), against an average of $127.7 million.
  • Year-over-year, Leases tumbled 94.31% in 2022 and then skyrocketed 1465.26% in 2023.
  • A 5-year view of Leases shows it stood at $174.2 million in 2021, then decreased by 4.15% to $167.0 million in 2022, then decreased by 13.95% to $143.7 million in 2023, then decreased by 18.62% to $117.0 million in 2024, then grew by 4.6% to $122.3 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Leases are $122.3 million (Q4 2025), $121.1 million (Q3 2025), and $126.1 million (Q2 2025).